No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
S&P/TSX Composite Index Ends 0.44% Higher at 25281.63 -- Data Talk
Barrick Looks Into Portfolio Optimization, Sees Pakistan As 'The New Frontier'
S&P/TSX Composite Index Ends 0.41% Higher at 25171.58 -- Data Talk
S&P/TSX Composite Index Ends the Week 1.21% Higher at 25067.92 -- Data Talk
Why Barrick Gold Stock Is Moving
Bausch Health And Salix Pharmaceuticals Announced That CMS Selected XIFAXAN 550 Mg For Drug Price Negotiation Under Inflation Reduction Act, Effective 2027; XIFAXAN Approved For HE And IBS-D In Adults, Rated Grade I, A,1 By Liver Disease Associations